Confo Therapeutics
Radu is a program leader at the MRC Laboratory of Molecular Biology (Cambridge, UK). His research focuses on synaptic connectivity, and uses a combination of structural biology methods, including X-ray crystallography and cryo-electron microscopy. These are used to define in high resolution the architecture of neurotransmitter receptors and their supra-molecular assemblies, in order to provide fundamental mechanistic insights into the basic biology of neurotransmission.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Confo Therapeutics
1 followers
Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery.